Neurogenetics tests in Dubai & UAE

Compare available Neurogenetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

-1.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurogenetics test prices

Showing 46–60 of 68 matching tests.

Neurogenetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3900 NTNG1 Gene Sequencing Test for Autism Spectrum Disorder (NGS) This diagnostic test evaluates the NTNG1 gene for pathogenic or likely pathogenic variants associated with Autism Spectrum Disorder (ASD).	Peripheral Whole Blood (EDTA)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NTNG1 gene", "Likely pathogenic variants in the NTNG1 gene"] Parameters [] Preparation [] Indications ["Children presenting with developmental delays, social communication deficits, repetitive behavioural patterns consistent with ASD", "Individuals with a positive family history of autism or unexplained neurodevelopmental disorders"] Measurement technique Confirm with laboratory Codes LOINC: 92821-0 ICD-10: F84.0 Clinical summary This diagnostic test evaluates the NTNG1 gene for pathogenic or likely pathogenic variants associated with Autism Spectrum Disorder (ASD).
TEST-5499 PANK2 Gene Pantothenate Kinase-Associated Neurodegeneration Genetic Test This test evaluates the PANK2 gene for pathogenic variants associated with Pantothenate Kinase-Associated Neurodegeneration (PKAN). It uses Next-Generation Sequencing (NGS) to prov...	Whole Blood (EDTA) or FTA Card (Finger-Prick)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PANK2 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Clinical suspicion of PKAN", "Family history of PKAN", "Carrier screening in affected families"] Measurement technique Confirm with laboratory Codes LOINC: 94233-2 ICD-10: G23.0 Clinical summary This test evaluates the PANK2 gene for pathogenic variants associated with Pantothenate Kinase-Associated Neurodegeneration (PKAN). It uses Next-Generation Sequencing (NGS) to provide comprehensive coverage of the gene.
TEST-4059 PMP22 Gene CMT1E Genetic Test This test identifies point mutations in the PMP22 gene associated with Charcot-Marie-Tooth disease type 1E (CMT1E).	Peripheral whole blood (EDTA), extracted DNA, or FTA card specimen	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PMP22 gene point mutations", "CMT1E genetic variants"] Parameters [] Preparation ["Provide detailed clinical history including age of onset, nerve conduction study results, and family pedigree.", "A DHA-certified genetic counselling session is mandatory prior to testing."] Indications ["Suspected Charcot-Marie-Tooth disease type 1E", "Negative MLPA testing for PMP22 duplication/deletion", "Family history of CMT1E"] Measurement technique Confirm with laboratory Codes LOINC: 52765-0 ICD-10: G60.0 Clinical summary This test identifies point mutations in the PMP22 gene associated with Charcot-Marie-Tooth disease type 1E (CMT1E).
TEST-4182 PMP22 Gene Dejerine-Sottas Disease Genetic Test This genetic test analyzes the PMP22 gene for pathogenic variants associated with Dejerine-Sottas disease (HMSN type III). It uses NGS and CNV analysis for comprehensive detection.	Peripheral whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks from sample collection	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PMP22 gene", "Copy Number Variations (CNVs) in the PMP22 gene"] Parameters [] Preparation [] Indications ["Confirmation of Dejerine-Sottas disease diagnosis", "Differentiation from other inherited neuropathies"] Measurement technique Confirm with laboratory Codes LOINC: 81246-0 ICD-10: G60.0, Z13.71, Z84.8 Clinical summary This genetic test analyzes the PMP22 gene for pathogenic variants associated with Dejerine-Sottas disease (HMSN type III). It uses NGS and CNV analysis for comprehensive detection.
TEST-4221 PNKP Gene Sequencing (Early Infantile Epileptic Encephalopathy Type 10) Test This test sequences the PNKP gene to identify mutations associated with Early Infantile Epileptic Encephalopathy Type 10 (EIEE10). It provides a definitive molecular diagnosis for...	Whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PNKP gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "Continue prescribed anti-epileptic medication unless advised otherwise by physician"] Indications ["Suspected Early Infantile Epileptic Encephalopathy Type 10 (EIEE10)", "Family history of EIEE10", "Need for precise genetic diagnosis for counselling and management"] Measurement technique Confirm with laboratory Codes LOINC: 83592-4 ICD-10: G40.4 Clinical summary This test sequences the PNKP gene to identify mutations associated with Early Infantile Epileptic Encephalopathy Type 10 (EIEE10). It provides a definitive molecular diagnosis for this severe neurodevelopmental condition.
TEST-5623 POLG2 Gene Progressive External Ophthalmoplegia Type 4 DNA Test This test evaluates the entire POLG2 gene for pathogenic variants associated with autosomal dominant progressive external ophthalmoplegia type 4.	Whole blood, extracted DNA, or FTA card	21–28 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the POLG2 gene", "Single nucleotide variants", "Small indels", "Copy number changes"] Parameters [] Preparation [] Indications ["Suspected diagnosis of autosomal dominant progressive external ophthalmoplegia type 4", "Family history of the disorder"] Measurement technique Confirm with laboratory Codes LOINC: 21665-7 ICD-10: H49.4 Clinical summary This test evaluates the entire POLG2 gene for pathogenic variants associated with autosomal dominant progressive external ophthalmoplegia type 4.
TEST-3876 RPL10 Gene (Autism Susceptibility, X‐Linked Intellectual Disability Type 5) Genetic Test This test identifies pathogenic variants in the RPL10 gene associated with X-linked intellectual disability type 5 and autism spectrum disorder.	Peripheral whole blood (EDTA) or buccal swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RPL10 gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of X-linked intellectual disability type 5", "Positive family history of RPL10-related disorders", "Evaluation of males with developmental delay and autism spectrum disorder"] Measurement technique Confirm with laboratory Codes LOINC: 100215-2 ICD-10: F84.0, F70 Clinical summary This test identifies pathogenic variants in the RPL10 gene associated with X-linked intellectual disability type 5 and autism spectrum disorder.
TEST-5608 SACS Gene Spastic Ataxia Charlevoix-Saguenay Type (ARSACS) Genetic Test This genetic test analyzes the SACS gene for mutations associated with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). It identifies pathogenic variants across...	Whole Blood (EDTA) or FTA Card Specimen	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SACS gene pathogenic variants", "Single nucleotide variants", "Small insertions or deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected ARSACS based on clinical presentation", "Family history of ARSACS", "Carrier screening in at-risk couples", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G11.1 Clinical summary This genetic test analyzes the SACS gene for mutations associated with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). It identifies pathogenic variants across the entire coding region and splice sites.
TEST-3080 SCA6 (Spinocerebellar Ataxia Type 6) Test This diagnostic test evaluates for CAG repeat expansions within the CACNA1A gene, which are characteristic of Spinocerebellar Ataxia Type 6.	Standard peripheral whole blood (4 mL EDTA)	4–5 days (Sample collected by Tuesday 11 am; Report delivered by Saturday)	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG repeat expansions in the CACNA1A gene"] Parameters [{"name": "CAG Repeat Length", "reference_range": "Normal: Preparation ["No fasting required", "No special preparation needed", "No medication modifications required"] Indications ["Suspected diagnosis of SCA6", "Family history of SCA6", "Differential diagnosis of ataxia"] Measurement technique Confirm with laboratory Codes LOINC: 83113-5 ICD-10: G11.2 Clinical summary This diagnostic test evaluates for CAG repeat expansions within the CACNA1A gene, which are characteristic of Spinocerebellar Ataxia Type 6.
TEST-5475 SCN9A Gene Neuropathy (HSAN2) Genetic Test This genetic test identifies disease-causing variants in the SCN9A gene associated with Hereditary Sensory and Autonomic Neuropathy Type 2 (HSAN2).	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spots (FTA Cards)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SCN9A gene", "Deletions/duplications in the SCN9A gene"] Parameters [] Preparation [] Indications ["Suspected Hereditary Sensory and Autonomic Neuropathy Type 2 (HSAN2)", "Confirmation of molecular diagnosis", "Family screening"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: G60.8 Clinical summary This genetic test identifies disease-causing variants in the SCN9A gene associated with Hereditary Sensory and Autonomic Neuropathy Type 2 (HSAN2).
TEST-4912 SMARCA4-Related Intellectual Disability (MRD16) Genetic Test This test detects genetic variants in the SMARCA4 gene associated with intellectual disability.	Peripheral whole blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMARCA4 gene variants (SNVs, Indels, CNVs)", "Chromatin remodeler gene function"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting a physician"] Indications ["Suspected SMARCA4-related intellectual disability (MRD16)", "Genetic counselling for intellectual disability", "Family history of MRD16"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: F78, Q87.8 Clinical summary This test detects genetic variants in the SMARCA4 gene associated with intellectual disability.
TEST-4829 SOX11 Gene Mental Retardation, Autosomal Dominant Type 27 Genetic Test This test identifies pathogenic variants within the SOX11 gene, which are associated with autosomal dominant intellectual disability type 27 (MRD27). It is used to confirm a diagno...	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SOX11 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No fasting required.", "Ensure child is well-hydrated and calm for blood draw."] Indications ["Suspected Autosomal Dominant Intellectual Disability Type 27 (MRD27)", "Unexplained developmental delay", "Family history of MRD27"] Measurement technique Confirm with laboratory Codes LOINC: 92822-6 ICD-10: Q87.89 Clinical summary This test identifies pathogenic variants within the SOX11 gene, which are associated with autosomal dominant intellectual disability type 27 (MRD27). It is used to confirm a diagnosis in individuals with suspected MRD27.
TEST-5694 SPG60 (WDR48 Gene) Genetic Test This test evaluates the WDR48 gene for pathogenic variants associated with autosomal recessive hereditary spastic paraplegia type 60 (SPG60). It detects single nucleotide variants,...	Whole Blood (peripheral)	3 to 4 Weeks	-1.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WDR48 gene variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Standard whole blood specimen"] Indications ["Suspected hereditary spastic paraplegia type 60", "Family history of SPG60", "Carrier screening", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 87808-4 ICD-10: G11.4 Clinical summary This test evaluates the WDR48 gene for pathogenic variants associated with autosomal recessive hereditary spastic paraplegia type 60 (SPG60). It detects single nucleotide variants, small insertions/deletions, and copy number variations.
TEST-5809 SPG7 Gene Genetic Test This test analyzes the SPG7 gene for pathogenic variants associated with Hereditary Spastic Paraplegia type 7.	Whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SPG7 gene", "Single-nucleotide variants", "Small indels", "Copy-number changes"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspicion of Hereditary Spastic Paraplegia type 7", "Diagnosis of progressive spastic-ataxic disorders", "Genetic counselling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G11.4 Clinical summary This test analyzes the SPG7 gene for pathogenic variants associated with Hereditary Spastic Paraplegia type 7.
TEST-3792 TARDBP Gene Amyotrophic Lateral Sclerosis Type 10 Genetic Test This test evaluates the TARDBP gene for pathogenic variants associated with Amyotrophic Lateral Sclerosis Type 10 (ALS10). It uses Next Generation Sequencing (NGS) to analyze the e...	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TARDBP gene", "Single nucleotide variants", "Small insertions or deletions"] Parameters [] Preparation [] Indications ["Individuals with a family history of ALS", "Clinical suspicion of inherited motor neuron disease", "Early-onset motor weakness"] Measurement technique Confirm with laboratory Codes LOINC: 96231-1 ICD-10: G12.21 Clinical summary This test evaluates the TARDBP gene for pathogenic variants associated with Amyotrophic Lateral Sclerosis Type 10 (ALS10). It uses Next Generation Sequencing (NGS) to analyze the entire coding region and splice junctions.

Category overview

Neurogenetics: overview

Securing a deep, fundamental understanding of your family's neurological blueprint allows for proactive, highly informed medical decisions that protect your long-term cognitive and motor vitality. As the core of our advanced neuro-diagnostic laboratory services, the Neurogenetics department utilizes state-of-the-art sequencing and targeted DNA analysis to uncover the precise genetic mutations driving rare brain, spinal cord, and peripheral nerve diseases. By leveraging advanced molecular technology, this expansive profiling helps establish an absolute diagnosis for elusive conditions, safely guiding your healthcare provider in tailoring highly personalized precision medicine, supportive therapies, and proactive family planning. Trusted for clinical rigor across premier diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical accuracy, and incredibly prompt turnaround times. Take an empowered step toward targeted neurological support—schedule your neurogenetics testing in UAE, coordinate a seamless clinic or home sample collection, or connect with our specialized specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.